The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
Demystifying Long COVID International Conference 2023
Related Enduring Materials
Enduring Materials
Day 1 - Thursday, 7 December 2023
Session 1 - Basic Facts about Long COVID -
Andrea Foulkes, ScD
Long COVID Prevalence, Incidence, and Risk Factors
Defining the Syndrome, and Clusters of Symptoms
Massachusetts General Hospital Biostatistics; Harvard Medical School, Harvard TH Chan School of Public Health, United States
Where the Gaps Are?
Day 2 - Friday, 8 December 2023
Session 2 - Pathogenesis of Long COVID -
Brent Appelman, MD
Etheresia Pretorius, PhD
Long COVID Pathogenesis - What Have We Learned So Far (Introduction Talk Presenting All the Current Hypotheses)
Mitochondrial Dysfunction - COVID, Muscles and Mitochondria
Center of Experimental and Molecular Medicine, Amsterdam Universitair Medische Centra, The Netherlands
Long COVID and Vascular Dysfunction
Stellenbosch University, South Africa; University of Liverpool, United Kingdom
SARS COV 2 Adaptative Immune Responses In Long COVID
Neuropathogenesis
The Hamster Model for Studying the Neurological Manifestations of Long COVID
Industry Supported Symposium I: SARS-CoV-2 Persistence and Long COVID: What Have We Learned So Far?
Session 3 - Clinical Management - Part I -
Current Treatment Options
Rehabilitation and Post-exertional Malaise Management
Long COVID in Pediatric and Adolescent Population
Session 4 - Clinical Management - Part II -
Neurocognitive and Neurological Symptoms
Parasympathetic Autonomic Dysfunction Is More Often Evidenced than Sympathetic Autonomic Dysfunction in Fluctuating and Polymorphic Symptoms of “Long-COVID” Patients
Day 3 - Saturday, 9 December 2023
Session 5 - Panel Discussion: Coordination and Challenges in the Care Pathway -
A Patient Perspective
A Perspective from a Family Doctor
A Two-Sided Coin: A Clinician and a Patient Perspective
A Perspective from an Infectious Diseases Doctor
Industry Supported Symposium II: Long COVID - Uncovering the Clues After 3 Years of Research
Session 6 - Treatment and Prevention of Long COVID: What Is on the Horizon? -
Carolyn Bramante, MD MPH
COVID-OUT Study
University of Minnesota Medical School, Department of Medicine, Division of General Internal Medicine, United States
Nirmatrelvir/ritonavir for Treatment of Long COVID: What Does the Clinical Data Show
End of program
Overview
About this Program
The Demystifying Long COVID International Conference 2023 took place on 7 - 9 December 2023 in Madrid, Spain.
The Demystifying Long COVID International Conference 2024 will take place on 21-23 November 2024 in Spain
The conference aimed to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community representatives on the clinical manifestations, management, plausible preventive and therapeutic options, and public health challenges related to long COVID (or post-acute sequelae of COVID-19).
The program featured state-of-the-art lectures, case presentations, and interactive sessions tailored to address educational needs in global healthcare settings. Ample time was reserved for debates and panel discussions to enhance knowledge exchange and reinforce the implementation of clinical guidelines and recommendations.
This was done in the unique context of the COVID-19 pandemic considering regional differences in epidemiology, morbidity and mortality, access to vaccines, tests, and medications, health system capacity, and public health measures.
General Information
Who Should Attend?
- Pulmonologists
- Neurologists
- Internal Medicine Physicians
- Infectious Diseases Physicians
- Family Doctors
- Cardiologists
- Psychiatrists
- Occupational Therapists
- Clinical/Translational investigators
- Policymakers
- Neurologists
- Internal Medicine Physicians
- Infectious Diseases Physicians
- Family Doctors
- Cardiologists
- Psychiatrists
- Occupational Therapists
- Clinical/Translational investigators
- Policymakers
Meeting Objectives
This meeting aimed to:
- Raising awareness and educating HCPs
- Facilitating translation of new findings into daily practice
- Stimulating clinical research and data sharing
- Raising awareness and educating HCPs
- Facilitating translation of new findings into daily practice
- Stimulating clinical research and data sharing
Learning Objectives
After participating in this activity, participants would be able to:
- Define the long COVID syndrome, and describe diagnostic challenges
- Understand epidemiology and trends in the prevalence in relation to the severity of acute COVID, the vaccination status, age, etc.
- Describe the multisystem pathologies of long COVID
- Improve management of people living with long COVID
- Summarize clinical data on potential preventive and treatment options
- Comprehend the impact on the economy and strategies to prioritize resources to better prepare the health systems and society globally
- Define the long COVID syndrome, and describe diagnostic challenges
- Understand epidemiology and trends in the prevalence in relation to the severity of acute COVID, the vaccination status, age, etc.
- Describe the multisystem pathologies of long COVID
- Improve management of people living with long COVID
- Summarize clinical data on potential preventive and treatment options
- Comprehend the impact on the economy and strategies to prioritize resources to better prepare the health systems and society globally
CME Accreditation
The Demystifying Long COVID International Conference 2023, Madrid, Spain 07/12/2023 - 09/12/2023, was accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Practical Information
We trust that the following information will assist you in organising your participation for the Demystifying Long COVID International Conference 2023.
Venue
This conference took place at Novotel Madrid Centre: Calle de O'Donnell, 53, 28009 Madrid, Spain
Language
The official language of the workshop was English. Translation was not provided.
Disclaimer
This conference was intended for educational purposes only and aimed to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Committees
Program Chairs
Local Chair
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the conference, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Founding Sponsor
Titanium Level
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in COVID-19.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored support package by contacting Ms. Kim Go at Kim.Go@amededu.com
Benefits of Support
By supporting this program, we can offer the following advantages for your company.*
Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Endorsers
The Demystifying Long COVID International Conference 2023 is endorsed by the following societies and organizations:
Become an Endorser
If you would like your organization to endorse or become a media partner of the Demystifying Long COVID International Conference 2023, please contact Ms. Hana Agustine at Hana.Agustine@amededu.com.
Media
Join us in Madrid!
Downloads:
Symposia
The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
Friday, 8 December 2023
Industry Supported Symposium: SARS-CoV-2 Persistence and Long COVID: What Have We Learned So Far? -
Long-Term Evolution of Long COVID
101 Virology – Retroviruses vs RNA viruses vs DNA Viruses – What We Know about the Persistence of Each and Virus-Induced Inflammation
Supporter
The "Industry Supported Symposium: SARS-CoV-2 Persistence and Long COVID: What Have We Learned So Far?" was supported by an independent educational grant from Shionogi. Shionogi was not involved in the development of content or selection of faculty for this educational activity.
Saturday, 9 December 2023
Industry Supported Symposium: Long COVID: Uncovering the Clues After 3 Years of Research - 9:30
Challenges in Long COVID Drug Development: Time to Re-Think Endpoints and the Role of Real-World Evidence
A Look at the Burden of Long COVID Under the Microscope
Speeding Up Long COVID Therapeutics: Biomarkers First?
Supporter
Photo Gallery
Group Photo (Onsite)
Group Photo (Virtual)
Conference Photos
Reports
Below reports are written by Mark Mascolini.
Defining long COVID
Preliminary Symptom Score Developed to Define Long COVID
Transcriptomics Sort Out Possible Markers and Mechanisms of Long COVID
Risk and impact of long COVID
Employment Type and Fear of Lost Income Tied to Persistent COVID Symptoms
Higher Vascular Markers in Neuropsychiatric Long COVID Point to Atherosclerosis Risk
Evolution and clinical features of long COVID
Reports From France and UK Confirm Frequent Intransigence of Long COVID
Immune Responses Rebound to Normal in Long COVID Group But One Third “Still Very Ill”
Prevention and treatment of long COVID
Metformin Cuts Long COVID Risk 41% in Placebo-Controlled COVID-OUT Trial
Baseline and Safety Data From Phase 2 Trial of Paxlovid to Treat Long COVID
Language
Related Programs
